APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-GMP Development

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Non-GMP Development Industry Growth and Trends Forecast to 2032

Report ID 17419828015 March 2026111 pages

Choose your research edition.

Industry ResearchNon-GMP Development Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-GMP Development Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Non-GMP Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-GMP Development Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-GMP Development Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Non-GMP Development market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-GMP Development is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Non-GMP Development market include Almac, GTP Technology, Alfa Aesar, Sundia-Manufacturing, J-STAR Research Inc., Lonza, AmbioPharm, Velesco and CordenPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Non-GMP Development market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Non-GMP Development market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Non-GMP Development market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Non-GMP Development.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Non-GMP Development market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Non-GMP Development Market by Company

Almac

GTP Technology

Alfa Aesar

Sundia-Manufacturing

J-STAR Research Inc.

Lonza

AmbioPharm

Velesco

CordenPharma

Piramal Pharma Solutions

Norwich

Aurigene Pharmaceutical Services

Actylis

CARBOGEN AMCIS

GTP Bioways

Symeres

Quotient Sciences

Non-GMP Development Segment by Type

Research Grade

Animal Free Grade

Non-GMP Development Segment by Application

Commercial & Academic

Clinical

Others

Non-GMP Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-GMP Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-GMP Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-GMP Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Non-GMP Development companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Non-GMP Development Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Non-GMP Development Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Non-GMP Development Market Share by Region (2021-2026) Table 4. Global Non-GMP Development Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Non-GMP Development Market Share by Region (2027-2032) Table 6. Global Non-GMP Development Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Non-GMP Development Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Non-GMP Development Market Size Share by Type (2021-2026) Table 9. Global Non-GMP Development Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Non-GMP Development Market Size Share Forecasted by Type (2027-2032) Table 11. North America Non-GMP Development Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Non-GMP Development Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Non-GMP Development Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Non-GMP Development Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Non-GMP Development Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Non-GMP Development Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Non-GMP Development Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Non-GMP Development Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Non-GMP Development Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Non-GMP Development Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Non-GMP Development Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Non-GMP Development Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Non-GMP Development Market Size Share by Application (2021-2026) Table 24. Global Non-GMP Development Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Non-GMP Development Market Size Share Forecasted by Application (2027-2032) Table 26. North America Non-GMP Development Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Non-GMP Development Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Non-GMP Development Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Non-GMP Development Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Non-GMP Development Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Non-GMP Development Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Non-GMP Development Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Non-GMP Development Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Non-GMP Development Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Non-GMP Development Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Non-GMP Development Industry Trends Table 37. Non-GMP Development Industry Drivers Table 38. Non-GMP Development Industry Opportunities and Challenges Table 39. Non-GMP Development Industry Restraints Table 40. Global Non-GMP Development Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Non-GMP Development Revenue Market Share by Company (2021-2026) Table 42. Global Non-GMP Development Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Non-GMP Development Key Company Headquarters & Area Served Table 44. Global Non-GMP Development Company, Product Type & Application Table 45. Global Non-GMP Development Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Non-GMP Development by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Almac Company Information Table 49. Almac Business Overview Table 50. Almac Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Almac Non-GMP Development Product Portfolio Table 52. Almac Recent Development Table 53. GTP Technology Company Information Table 54. GTP Technology Business Overview Table 55. GTP Technology Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. GTP Technology Non-GMP Development Product Portfolio Table 57. GTP Technology Recent Development Table 58. Alfa Aesar Company Information Table 59. Alfa Aesar Business Overview Table 60. Alfa Aesar Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Alfa Aesar Non-GMP Development Product Portfolio Table 62. Alfa Aesar Recent Development Table 63. Sundia-Manufacturing Company Information Table 64. Sundia-Manufacturing Business Overview Table 65. Sundia-Manufacturing Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sundia-Manufacturing Non-GMP Development Product Portfolio Table 67. Sundia-Manufacturing Recent Development Table 68. J-STAR Research Inc. Company Information Table 69. J-STAR Research Inc. Business Overview Table 70. J-STAR Research Inc. Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. J-STAR Research Inc. Non-GMP Development Product Portfolio Table 72. J-STAR Research Inc. Recent Development Table 73. Lonza Company Information Table 74. Lonza Business Overview Table 75. Lonza Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Lonza Non-GMP Development Product Portfolio Table 77. Lonza Recent Development Table 78. AmbioPharm Company Information Table 79. AmbioPharm Business Overview Table 80. AmbioPharm Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AmbioPharm Non-GMP Development Product Portfolio Table 82. AmbioPharm Recent Development Table 83. Velesco Company Information Table 84. Velesco Business Overview Table 85. Velesco Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Velesco Non-GMP Development Product Portfolio Table 87. Velesco Recent Development Table 88. CordenPharma Company Information Table 89. CordenPharma Business Overview Table 90. CordenPharma Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. CordenPharma Non-GMP Development Product Portfolio Table 92. CordenPharma Recent Development Table 93. Piramal Pharma Solutions Company Information Table 94. Piramal Pharma Solutions Business Overview Table 95. Piramal Pharma Solutions Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Piramal Pharma Solutions Non-GMP Development Product Portfolio Table 97. Piramal Pharma Solutions Recent Development Table 98. Norwich Company Information Table 99. Norwich Business Overview Table 100. Norwich Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Norwich Non-GMP Development Product Portfolio Table 102. Norwich Recent Development Table 103. Aurigene Pharmaceutical Services Company Information Table 104. Aurigene Pharmaceutical Services Business Overview Table 105. Aurigene Pharmaceutical Services Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Aurigene Pharmaceutical Services Non-GMP Development Product Portfolio Table 107. Aurigene Pharmaceutical Services Recent Development Table 108. Actylis Company Information Table 109. Actylis Business Overview Table 110. Actylis Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Actylis Non-GMP Development Product Portfolio Table 112. Actylis Recent Development Table 113. CARBOGEN AMCIS Company Information Table 114. CARBOGEN AMCIS Business Overview Table 115. CARBOGEN AMCIS Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. CARBOGEN AMCIS Non-GMP Development Product Portfolio Table 117. CARBOGEN AMCIS Recent Development Table 118. GTP Bioways Company Information Table 119. GTP Bioways Business Overview Table 120. GTP Bioways Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. GTP Bioways Non-GMP Development Product Portfolio Table 122. GTP Bioways Recent Development Table 123. Symeres Company Information Table 124. Symeres Business Overview Table 125. Symeres Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Symeres Non-GMP Development Product Portfolio Table 127. Symeres Recent Development Table 128. Quotient Sciences Company Information Table 129. Quotient Sciences Business Overview Table 130. Quotient Sciences Non-GMP Development Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Quotient Sciences Non-GMP Development Product Portfolio Table 132. Quotient Sciences Recent Development Table 133. North America Non-GMP Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Non-GMP Development Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Non-GMP Development Market Share by Country (2021-2026) Table 136. North America Non-GMP Development Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Non-GMP Development Market Share Forecast by Country (2027-2032) Table 138. Europe Non-GMP Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Non-GMP Development Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Non-GMP Development Market Share by Country (2021-2026) Table 141. Europe Non-GMP Development Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Non-GMP Development Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Non-GMP Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Non-GMP Development Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Non-GMP Development Market Share by Country (2021-2026) Table 146. Asia-Pacific Non-GMP Development Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Non-GMP Development Market Share Forecast by Country (2027-2032) Table 148. Latin America Non-GMP Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Non-GMP Development Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Non-GMP Development Market Share by Country (2021-2026) Table 151. Latin America Non-GMP Development Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Non-GMP Development Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Non-GMP Development Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Non-GMP Development Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Non-GMP Development Market Share by Country (2021-2026) Table 156. Middle East & Africa Non-GMP Development Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Non-GMP Development Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Non-GMP Development Product Image Figure 3. Global Non-GMP Development Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Non-GMP Development Market Size (2021-2032) & (US$ Million) Figure 5. Global Non-GMP Development Market Share by Region: 2025 VS 2032 Figure 6. Global Non-GMP Development Market Share by Region (2021-2032) Figure 7. North America Non-GMP Development Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Non-GMP Development Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Non-GMP Development Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Non-GMP Development Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Non-GMP Development Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Research Grade Image Figure 13. Global Research Grade Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Animal Free Grade Image Figure 15. Global Animal Free Grade Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Non-GMP Development Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Non-GMP Development Market Share by Type 2025 VS 2032 Figure 18. North America Non-GMP Development Market Size Share by Type (2021-2032) Figure 19. Europe Non-GMP Development Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Non-GMP Development Market Size Share by Type (2021-2032) Figure 21. Latin America Non-GMP Development Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Non-GMP Development Market Size Share by Type (2021-2032) Figure 23. Commercial & Academic Image Figure 24. Global Commercial & Academic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinical Image Figure 26. Global Clinical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Non-GMP Development Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Non-GMP Development Market Share by Application 2025 VS 2032 Figure 31. North America Non-GMP Development Market Size Share by Application (2021-2032) Figure 32. Europe Non-GMP Development Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Non-GMP Development Market Size Share by Application (2021-2032) Figure 34. Latin America Non-GMP Development Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Non-GMP Development Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Non-GMP Development Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Non-GMP Development Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Non-GMP Development Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Non-GMP Development Market Share by Country (2021-2032) Figure 41. Europe Non-GMP Development Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Non-GMP Development Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Non-GMP Development Market Share by Country (2021-2032) Figure 44. Asia-Pacific Non-GMP Development Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Non-GMP Development Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Non-GMP Development Market Share by Country (2021-2032) Figure 47. Latin America Non-GMP Development Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Non-GMP Development Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Non-GMP Development Market Share by Country (2021-2032) Figure 50. Middle East & Africa Non-GMP Development Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Non-GMP Development Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Non-GMP Development Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade
  • Animal Free Grade
Applications
  • Commercial & Academic
  • Clinical
  • Others
Companies covered
  • Almac
  • GTP Technology
  • Alfa Aesar
  • Sundia-Manufacturing
  • J-STAR Research Inc.
  • Lonza
  • AmbioPharm
  • Velesco
  • CordenPharma
  • Piramal Pharma Solutions
  • Norwich
  • Aurigene Pharmaceutical Services
  • Actylis
  • CARBOGEN AMCIS
  • GTP Bioways
  • Symeres
  • Quotient Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Non-GMP Development Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Non-GMP Development Market Size by Region (2021-2032)
  5. 1.4.1 Global Non-GMP Development Market Size by Region (2021-2026)
  6. 1.4.2 Global Non-GMP Development Market Size by Region (2027-2032)
  7. 1.5 Key Regions Non-GMP Development Market Size (2021-2032)
  8. 1.5.1 North America Non-GMP Development Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Non-GMP Development Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Non-GMP Development Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Non-GMP Development Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Non-GMP Development Market Size Growth Rate (2021-2032)
2 Non-GMP Development Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Research Grade
  3. 2.1.2 Animal Free Grade
  4. 2.2 Global Non-GMP Development Market Size by Type
  5. 2.2.1 Global Non-GMP Development Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Non-GMP Development Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Non-GMP Development Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Non-GMP Development Market Size by Regions
  9. 2.3.1 North America Non-GMP Development Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Non-GMP Development Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Non-GMP Development Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Non-GMP Development Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Non-GMP Development Market Size Breakdown by Type (2021-2026)
3 Non-GMP Development Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Commercial & Academic
  3. 3.1.2 Clinical
  4. 3.1.3 Others
  5. 3.2 Global Non-GMP Development Market Size by Application
  6. 3.2.1 Global Non-GMP Development Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Non-GMP Development Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Non-GMP Development Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Non-GMP Development Market Size by Regions
  10. 3.3.1 North America Non-GMP Development Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Non-GMP Development Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Non-GMP Development Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Non-GMP Development Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Non-GMP Development Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Non-GMP Development Industry Trends
  2. 4.2 Non-GMP Development Industry Drivers
  3. 4.3 Non-GMP Development Industry Opportunities and Challenges
  4. 4.4 Non-GMP Development Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Non-GMP Development Revenue (2021-2026)
  2. 5.2 Global Non-GMP Development Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Non-GMP Development Key Company Headquarters & Area Served
  4. 5.4 Global Non-GMP Development Company, Product Type & Application
  5. 5.5 Global Non-GMP Development Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Non-GMP Development Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Non-GMP Development Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Non-GMP Development Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Almac
  2. 6.1.1 Almac Company Information
  3. 6.1.2 Almac Business Overview
  4. 6.1.3 Almac Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Almac Non-GMP Development Product Portfolio
  6. 6.1.5 Almac Recent Developments
  7. 6.2 GTP Technology
  8. 6.2.1 GTP Technology Company Information
  9. 6.2.2 GTP Technology Business Overview
  10. 6.2.3 GTP Technology Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 GTP Technology Non-GMP Development Product Portfolio
  12. 6.2.5 GTP Technology Recent Developments
  13. 6.3 Alfa Aesar
  14. 6.3.1 Alfa Aesar Company Information
  15. 6.3.2 Alfa Aesar Business Overview
  16. 6.3.3 Alfa Aesar Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Alfa Aesar Non-GMP Development Product Portfolio
  18. 6.3.5 Alfa Aesar Recent Developments
  19. 6.4 Sundia-Manufacturing
  20. 6.4.1 Sundia-Manufacturing Company Information
  21. 6.4.2 Sundia-Manufacturing Business Overview
  22. 6.4.3 Sundia-Manufacturing Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sundia-Manufacturing Non-GMP Development Product Portfolio
  24. 6.4.5 Sundia-Manufacturing Recent Developments
  25. 6.5 J-STAR Research Inc.
  26. 6.5.1 J-STAR Research Inc. Company Information
  27. 6.5.2 J-STAR Research Inc. Business Overview
  28. 6.5.3 J-STAR Research Inc. Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 J-STAR Research Inc. Non-GMP Development Product Portfolio
  30. 6.5.5 J-STAR Research Inc. Recent Developments
  31. 6.6 Lonza
  32. 6.6.1 Lonza Company Information
  33. 6.6.2 Lonza Business Overview
  34. 6.6.3 Lonza Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Lonza Non-GMP Development Product Portfolio
  36. 6.6.5 Lonza Recent Developments
  37. 6.7 AmbioPharm
  38. 6.7.1 AmbioPharm Company Information
  39. 6.7.2 AmbioPharm Business Overview
  40. 6.7.3 AmbioPharm Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AmbioPharm Non-GMP Development Product Portfolio
  42. 6.7.5 AmbioPharm Recent Developments
  43. 6.8 Velesco
  44. 6.8.1 Velesco Company Information
  45. 6.8.2 Velesco Business Overview
  46. 6.8.3 Velesco Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Velesco Non-GMP Development Product Portfolio
  48. 6.8.5 Velesco Recent Developments
  49. 6.9 CordenPharma
  50. 6.9.1 CordenPharma Company Information
  51. 6.9.2 CordenPharma Business Overview
  52. 6.9.3 CordenPharma Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 CordenPharma Non-GMP Development Product Portfolio
  54. 6.9.5 CordenPharma Recent Developments
  55. 6.10 Piramal Pharma Solutions
  56. 6.10.1 Piramal Pharma Solutions Company Information
  57. 6.10.2 Piramal Pharma Solutions Business Overview
  58. 6.10.3 Piramal Pharma Solutions Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions Non-GMP Development Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions Recent Developments
  61. 6.11 Norwich
  62. 6.11.1 Norwich Company Information
  63. 6.11.2 Norwich Business Overview
  64. 6.11.3 Norwich Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Norwich Non-GMP Development Product Portfolio
  66. 6.11.5 Norwich Recent Developments
  67. 6.12 Aurigene Pharmaceutical Services
  68. 6.12.1 Aurigene Pharmaceutical Services Company Information
  69. 6.12.2 Aurigene Pharmaceutical Services Business Overview
  70. 6.12.3 Aurigene Pharmaceutical Services Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Aurigene Pharmaceutical Services Non-GMP Development Product Portfolio
  72. 6.12.5 Aurigene Pharmaceutical Services Recent Developments
  73. 6.13 Actylis
  74. 6.13.1 Actylis Company Information
  75. 6.13.2 Actylis Business Overview
  76. 6.13.3 Actylis Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Actylis Non-GMP Development Product Portfolio
  78. 6.13.5 Actylis Recent Developments
  79. 6.14 CARBOGEN AMCIS
  80. 6.14.1 CARBOGEN AMCIS Company Information
  81. 6.14.2 CARBOGEN AMCIS Business Overview
  82. 6.14.3 CARBOGEN AMCIS Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 CARBOGEN AMCIS Non-GMP Development Product Portfolio
  84. 6.14.5 CARBOGEN AMCIS Recent Developments
  85. 6.15 GTP Bioways
  86. 6.15.1 GTP Bioways Company Information
  87. 6.15.2 GTP Bioways Business Overview
  88. 6.15.3 GTP Bioways Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 GTP Bioways Non-GMP Development Product Portfolio
  90. 6.15.5 GTP Bioways Recent Developments
  91. 6.16 Symeres
  92. 6.16.1 Symeres Company Information
  93. 6.16.2 Symeres Business Overview
  94. 6.16.3 Symeres Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Symeres Non-GMP Development Product Portfolio
  96. 6.16.5 Symeres Recent Developments
  97. 6.17 Quotient Sciences
  98. 6.17.1 Quotient Sciences Company Information
  99. 6.17.2 Quotient Sciences Business Overview
  100. 6.17.3 Quotient Sciences Non-GMP Development Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Quotient Sciences Non-GMP Development Product Portfolio
  102. 6.17.5 Quotient Sciences Recent Developments
7 North America
  1. 7.1 North America Non-GMP Development Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Non-GMP Development Market Size by Country (2021-2026)
  3. 7.3 North America Non-GMP Development Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Non-GMP Development Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Non-GMP Development Market Size by Country (2021-2026)
  3. 8.3 Europe Non-GMP Development Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Non-GMP Development Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Non-GMP Development Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Non-GMP Development Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Non-GMP Development Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Non-GMP Development Market Size by Country (2021-2026)
  3. 10.3 South America Non-GMP Development Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Non-GMP Development Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Non-GMP Development Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Non-GMP Development Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst